erbb species Search Results


86
Thermo Fisher gene exp egfr hs01076092 m1
Gene Exp Egfr Hs01076092 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gene exp egfr hs01076092 m1/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
gene exp egfr hs01076092 m1 - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

95
Santa Cruz Biotechnology erbb2 her2 specific mouse mab
Erbb2 Her2 Specific Mouse Mab, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erbb2 her2 specific mouse mab/product/Santa Cruz Biotechnology
Average 95 stars, based on 1 article reviews
erbb2 her2 specific mouse mab - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

94
Proteintech anti egfr a2b1
Anti Egfr A2b1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti egfr a2b1/product/Proteintech
Average 94 stars, based on 1 article reviews
anti egfr a2b1 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier

90
ERBA Diagnostics hemavet® 950fs multi-species hematology system
Hemavet® 950fs Multi Species Hematology System, supplied by ERBA Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hemavet® 950fs multi-species hematology system/product/ERBA Diagnostics
Average 90 stars, based on 1 article reviews
hemavet® 950fs multi-species hematology system - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
China Center for Type Culture Collection human normal mammary epithelial cell line mcf-10a
Human Normal Mammary Epithelial Cell Line Mcf 10a, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human normal mammary epithelial cell line mcf-10a/product/China Center for Type Culture Collection
Average 90 stars, based on 1 article reviews
human normal mammary epithelial cell line mcf-10a - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Bacus Laboratories erbb2 tyrosine kinase inhibitor
Erbb2 Tyrosine Kinase Inhibitor, supplied by Bacus Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erbb2 tyrosine kinase inhibitor/product/Bacus Laboratories
Average 90 stars, based on 1 article reviews
erbb2 tyrosine kinase inhibitor - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

lin28  (Abcam)
99
Abcam lin28
Lin28, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/lin28/product/Abcam
Average 99 stars, based on 1 article reviews
lin28 - by Bioz Stars, 2026-06
99/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology erbb3
Erbb3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erbb3/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
erbb3 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier

90
OriGene c erbb 2
C Erbb 2, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c erbb 2/product/OriGene
Average 90 stars, based on 1 article reviews
c erbb 2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

95
Selleck Chemicals erbb tyrosine kinase inhibitors
Expression of <t>ErbB</t> receptors in surgically resected patient cholangiocarcinoma (CCA) tissue. (A) Absolute RNA expression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor (HER) 2, HER3, and HER4 transcript levels in paired CCA patient resected tissue and adjacent margin, detected by droplet digital polymerase chain reaction (ddPCR). Significant difference was determined by paired t test. (B) Absolute expression of EGFR, HER2, HER3, and HER4 transcript levels in primary CCA cells isolated from the tumor tissue and primary cells from normal tissue margins, detected by ddPCR. Significant difference was determined by Welch’s t test. *p < 0.05, **p < 0.01, ***p < 0.001 compared with margin. (C) Immunohistochemistry for ErbB proteins in CCA tissues. EGFR: placenta (positive control EGFR); breast cancer (positive control HER2 and HER3) and normal liver (positive control HER4). Immunopositive cells stained with 3,3′-diaminobenzidine (brown) and counterstained with hematoxylin (blue). Asterisks indicate tumor margin. Scale bars=50 μm.
Erbb Tyrosine Kinase Inhibitors, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/erbb tyrosine kinase inhibitors/product/Selleck Chemicals
Average 95 stars, based on 1 article reviews
erbb tyrosine kinase inhibitors - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier

90
bioMerieux gmbh api 20 ne
Expression of <t>ErbB</t> receptors in surgically resected patient cholangiocarcinoma (CCA) tissue. (A) Absolute RNA expression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor (HER) 2, HER3, and HER4 transcript levels in paired CCA patient resected tissue and adjacent margin, detected by droplet digital polymerase chain reaction (ddPCR). Significant difference was determined by paired t test. (B) Absolute expression of EGFR, HER2, HER3, and HER4 transcript levels in primary CCA cells isolated from the tumor tissue and primary cells from normal tissue margins, detected by ddPCR. Significant difference was determined by Welch’s t test. *p < 0.05, **p < 0.01, ***p < 0.001 compared with margin. (C) Immunohistochemistry for ErbB proteins in CCA tissues. EGFR: placenta (positive control EGFR); breast cancer (positive control HER2 and HER3) and normal liver (positive control HER4). Immunopositive cells stained with 3,3′-diaminobenzidine (brown) and counterstained with hematoxylin (blue). Asterisks indicate tumor margin. Scale bars=50 μm.
Api 20 Ne, supplied by bioMerieux gmbh, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/api 20 ne/product/bioMerieux gmbh
Average 90 stars, based on 1 article reviews
api 20 ne - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Erbe Elektromedizin GmbH vio electrosurgical units
Expression of <t>ErbB</t> receptors in surgically resected patient cholangiocarcinoma (CCA) tissue. (A) Absolute RNA expression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor (HER) 2, HER3, and HER4 transcript levels in paired CCA patient resected tissue and adjacent margin, detected by droplet digital polymerase chain reaction (ddPCR). Significant difference was determined by paired t test. (B) Absolute expression of EGFR, HER2, HER3, and HER4 transcript levels in primary CCA cells isolated from the tumor tissue and primary cells from normal tissue margins, detected by ddPCR. Significant difference was determined by Welch’s t test. *p < 0.05, **p < 0.01, ***p < 0.001 compared with margin. (C) Immunohistochemistry for ErbB proteins in CCA tissues. EGFR: placenta (positive control EGFR); breast cancer (positive control HER2 and HER3) and normal liver (positive control HER4). Immunopositive cells stained with 3,3′-diaminobenzidine (brown) and counterstained with hematoxylin (blue). Asterisks indicate tumor margin. Scale bars=50 μm.
Vio Electrosurgical Units, supplied by Erbe Elektromedizin GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vio electrosurgical units/product/Erbe Elektromedizin GmbH
Average 90 stars, based on 1 article reviews
vio electrosurgical units - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Expression of ErbB receptors in surgically resected patient cholangiocarcinoma (CCA) tissue. (A) Absolute RNA expression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor (HER) 2, HER3, and HER4 transcript levels in paired CCA patient resected tissue and adjacent margin, detected by droplet digital polymerase chain reaction (ddPCR). Significant difference was determined by paired t test. (B) Absolute expression of EGFR, HER2, HER3, and HER4 transcript levels in primary CCA cells isolated from the tumor tissue and primary cells from normal tissue margins, detected by ddPCR. Significant difference was determined by Welch’s t test. *p < 0.05, **p < 0.01, ***p < 0.001 compared with margin. (C) Immunohistochemistry for ErbB proteins in CCA tissues. EGFR: placenta (positive control EGFR); breast cancer (positive control HER2 and HER3) and normal liver (positive control HER4). Immunopositive cells stained with 3,3′-diaminobenzidine (brown) and counterstained with hematoxylin (blue). Asterisks indicate tumor margin. Scale bars=50 μm.

Journal: Cancer Research and Treatment : Official Journal of Korean Cancer Association

Article Title: Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

doi: 10.4143/crt.2020.585

Figure Lengend Snippet: Expression of ErbB receptors in surgically resected patient cholangiocarcinoma (CCA) tissue. (A) Absolute RNA expression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor (HER) 2, HER3, and HER4 transcript levels in paired CCA patient resected tissue and adjacent margin, detected by droplet digital polymerase chain reaction (ddPCR). Significant difference was determined by paired t test. (B) Absolute expression of EGFR, HER2, HER3, and HER4 transcript levels in primary CCA cells isolated from the tumor tissue and primary cells from normal tissue margins, detected by ddPCR. Significant difference was determined by Welch’s t test. *p < 0.05, **p < 0.01, ***p < 0.001 compared with margin. (C) Immunohistochemistry for ErbB proteins in CCA tissues. EGFR: placenta (positive control EGFR); breast cancer (positive control HER2 and HER3) and normal liver (positive control HER4). Immunopositive cells stained with 3,3′-diaminobenzidine (brown) and counterstained with hematoxylin (blue). Asterisks indicate tumor margin. Scale bars=50 μm.

Article Snippet: The proliferative effect of specific ErbB tyrosine kinase inhibitors (afatinib, lapatinib, and erlotinib) (Selleckchem) on human CCA cells was determined by MTT assay.

Techniques: Expressing, RNA Expression, Digital PCR, Isolation, Immunohistochemistry, Positive Control, Staining

Percentage of  ErbB  stained tumor from the UK and Thai patients

Journal: Cancer Research and Treatment : Official Journal of Korean Cancer Association

Article Title: Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

doi: 10.4143/crt.2020.585

Figure Lengend Snippet: Percentage of ErbB stained tumor from the UK and Thai patients

Article Snippet: The proliferative effect of specific ErbB tyrosine kinase inhibitors (afatinib, lapatinib, and erlotinib) (Selleckchem) on human CCA cells was determined by MTT assay.

Techniques: Staining, Immunohistochemistry

The percentage of cell survival of different four cholangiocarcinoma cell lines treated with various concentrations of ErbB inhibitors at 48 hours by MTT assay. Afatinib (A), lapatinib (B), and erlotinib (C). The percentage cell survival of the combined treatments of fixed concentration of gemcitabine (0.1 μM) with afatinib, lapatinib, and erlotinib (0.1, 1, and 10 μM) in HuCCA-1 cells (D) and KKU-M213 (E). *p < 0.05 compared with untreated control group, # p < 0.05 compared with the gemcitabine-treated group The combination effect is described as synergism (blue), or antagonism (red) according to the combination index value.

Journal: Cancer Research and Treatment : Official Journal of Korean Cancer Association

Article Title: Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

doi: 10.4143/crt.2020.585

Figure Lengend Snippet: The percentage of cell survival of different four cholangiocarcinoma cell lines treated with various concentrations of ErbB inhibitors at 48 hours by MTT assay. Afatinib (A), lapatinib (B), and erlotinib (C). The percentage cell survival of the combined treatments of fixed concentration of gemcitabine (0.1 μM) with afatinib, lapatinib, and erlotinib (0.1, 1, and 10 μM) in HuCCA-1 cells (D) and KKU-M213 (E). *p < 0.05 compared with untreated control group, # p < 0.05 compared with the gemcitabine-treated group The combination effect is described as synergism (blue), or antagonism (red) according to the combination index value.

Article Snippet: The proliferative effect of specific ErbB tyrosine kinase inhibitors (afatinib, lapatinib, and erlotinib) (Selleckchem) on human CCA cells was determined by MTT assay.

Techniques: MTT Assay, Concentration Assay, Control

IC 50 value (μM) of the specific  ErbB   inhibitors  at 48 hours

Journal: Cancer Research and Treatment : Official Journal of Korean Cancer Association

Article Title: Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

doi: 10.4143/crt.2020.585

Figure Lengend Snippet: IC 50 value (μM) of the specific ErbB inhibitors at 48 hours

Article Snippet: The proliferative effect of specific ErbB tyrosine kinase inhibitors (afatinib, lapatinib, and erlotinib) (Selleckchem) on human CCA cells was determined by MTT assay.

Techniques:

Effect of ErbB inhibitors on primary cholangiocarcinoma (CCA) lines in 3D-tumor growth assay (TGA). (A) Four primary cells were derived from surgically resected CCA tissue samples; CCA-UK5, CCA-UK6, CCA-UK7, and CCA-UK9. Primary cells (dashed), matched cancer associated fibroblasts (CAFs) also derived from the same tissue samples (solid), a human mesenchymal cell line (mesenchymal stem cell [MSC] not shown) or a mixture (CAF+cancer cells shown as dotted line) were employed for the 3D-TGA. (B) Growth of cells, CAFs, and primary cells and CAF (red line) or MSC (green line) mixed with the primary cells was measured using AlamarBlue. Percent cell survival of CCA1 and CCA2 treated with gemcitabine/cisplatin (Gem/Cis) (C), erlotinib (D), or afatinib (E). The mean±20% peak serum concentration for patients is given as the dotted and shaded lines (grey).

Journal: Cancer Research and Treatment : Official Journal of Korean Cancer Association

Article Title: Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

doi: 10.4143/crt.2020.585

Figure Lengend Snippet: Effect of ErbB inhibitors on primary cholangiocarcinoma (CCA) lines in 3D-tumor growth assay (TGA). (A) Four primary cells were derived from surgically resected CCA tissue samples; CCA-UK5, CCA-UK6, CCA-UK7, and CCA-UK9. Primary cells (dashed), matched cancer associated fibroblasts (CAFs) also derived from the same tissue samples (solid), a human mesenchymal cell line (mesenchymal stem cell [MSC] not shown) or a mixture (CAF+cancer cells shown as dotted line) were employed for the 3D-TGA. (B) Growth of cells, CAFs, and primary cells and CAF (red line) or MSC (green line) mixed with the primary cells was measured using AlamarBlue. Percent cell survival of CCA1 and CCA2 treated with gemcitabine/cisplatin (Gem/Cis) (C), erlotinib (D), or afatinib (E). The mean±20% peak serum concentration for patients is given as the dotted and shaded lines (grey).

Article Snippet: The proliferative effect of specific ErbB tyrosine kinase inhibitors (afatinib, lapatinib, and erlotinib) (Selleckchem) on human CCA cells was determined by MTT assay.

Techniques: Growth Assay, Derivative Assay, Concentration Assay